News And Events

IntroductionHave you ever wondered how flow cytometry achieves such precise and reliable cell analysis? The key to accurate results lies in proper cell fixation. Flow cytometry allows researchers to study a variety of cellular characteristics, from size to fluorescence intensity. Read More

Introduction Flow cytometry is a powerful technique used to analyze the physical and chemical properties of cells and particles. As technology advances, its efficiency and speed have drastically improved, making it indispensable in research and clinical diagnostics. Read More

IntroductionHave you ever wondered how scientists analyze thousands of cells in just a few seconds? Flow cytometry is the powerful tool that makes this possible. It allows researchers to study the physical and chemical properties of individual cells quickly and accurately. Read More

IntroductionHave you ever wondered how researchers analyze thousands of cells in just a few minutes? Flow Cytometry makes this possible. This technique offers a rapid, multi-dimensional analysis of individual cells, revealing crucial insights into their physical and chemical properties. Read More

IntroductionHave you ever wondered how scientists analyze and sort individual cells in seconds? Flow cytometry makes this possible. This powerful technique helps researchers study cell characteristics, playing a vital role in fields like cancer research, immunology, and microbiology. Read More

Type 1 diabetes (T1D) is a complex autoimmune disease characterized by the immune system’s destruction of insulin-producing β-cells in the pancreas. Read More

In preclinical studies of type 1 diabetes (T1D), accurate measurement of blood glucose levels and assessment of beta-cell mass are critical for understanding disease progression and therapeutic efficacy. Read More

Beta-cell destruction is a defining feature of type 1 diabetes (T1D), where the body’s own immune system selectively targets and destroys insulin-producing cells in the pancreas. Read More

Balancing the protection of insulin-producing beta cells with effective immune control remains the central therapeutic challenge in autoimmune diabetes. Read More